Re: p27Kip1 and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy [1]

Journal of the National Cancer Institute

Volumn 99, Issue 9, 2007, Pages 738-

  Span, Paul N ^a   de Mulder, Pieter H ^a   Sweep, Fred C G J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; CYCLOPHOSPHAMIDE; DOXORUBICIN; PROTEIN ANTIBODY; TAMOXIFEN;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RESISTANCE; CANCER SURVIVAL; DISEASE COURSE; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTERMETHOD COMPARISON; LETTER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TISSUE MICROARRAY; TREATMENT OUTCOME; WESTERN BLOTTING; BREAST TUMOR; FEMALE; GENETICS; MORTALITY; NOTE; SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; HUMANS; SURVIVAL ANALYSIS;

EID: 34249749461     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djk163     Document Type: Letter

References (5)

1. Porter PLP, Barlow WE, Yeh IT, Lin MG, Yuan XP, Donato E, et al. p27Kip1 and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy. J Natl Cancer Inst 2006;98:1723-31.
2. Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002;347:1566-75.
3. Span PN, Tjan-Heijnen VC, Manders P, Beex LV, Sweep CG. Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer. Oncogene 2003;22:4898-904.
4. Akli S, Zheng PJ, Multani AS, Wingate HF, Pathak S, Zhang N, et al. Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer. Cancer Res 2004;64:3198-208.
5. Desmedt C, Ouriaghli FE, Durbecq V, Soree A, Colozza MA, Azambuja E, et al. Impact of cyclins E, neutrophil elastase and proteinase 3 expression levels on clinical outcome in primary breast cancer patients. Int J Cancer 2006;119:2539-45.